229 related articles for article (PubMed ID: 25869538)
1. Naturally acquired antibody responses to recombinant Pfs230 and Pfs48/45 transmission blocking vaccine candidates.
Jones S; Grignard L; Nebie I; Chilongola J; Dodoo D; Sauerwein R; Theisen M; Roeffen W; Singh SK; Singh RK; Singh S; Kyei-Baafour E; Tetteh K; Drakeley C; Bousema T
J Infect; 2015 Jul; 71(1):117-27. PubMed ID: 25869538
[TBL] [Abstract][Full Text] [Related]
2. The dynamics of naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs230 & Pfs48/45 in a low endemic area in Tanzania.
Bousema T; Roeffen W; Meijerink H; Mwerinde H; Mwakalinga S; van Gemert GJ; van de Vegte-Bolmer M; Mosha F; Targett G; Riley EM; Sauerwein R; Drakeley C
PLoS One; 2010 Nov; 5(11):e14114. PubMed ID: 21124765
[TBL] [Abstract][Full Text] [Related]
3. Naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs48/45 and Pfs230 in an area of seasonal transmission.
Ouédraogo AL; Roeffen W; Luty AJ; de Vlas SJ; Nebie I; Ilboudo-Sanogo E; Cuzin-Ouattara N; Teleen K; Tiono AB; Sirima SB; Verhave JP; Bousema T; Sauerwein R
Infect Immun; 2011 Dec; 79(12):4957-64. PubMed ID: 21969000
[TBL] [Abstract][Full Text] [Related]
4. Associations Between Helminth Infections, Plasmodium falciparum Parasite Carriage and Antibody Responses to Sexual and Asexual Stage Malarial Antigens.
Ateba-Ngoa U; Jones S; Zinsou JF; Honkpehedji J; Adegnika AA; Agobe JC; Massinga-Loembe M; Mordmüller B; Bousema T; Yazdanbakhsh M
Am J Trop Med Hyg; 2016 Aug; 95(2):394-400. PubMed ID: 27273645
[TBL] [Abstract][Full Text] [Related]
5.
Singh SK; Thrane S; Chourasia BK; Teelen K; Graumans W; Stoter R; van Gemert GJ; van de Vegte-Bolmer MG; Nielsen MA; Salanti A; Sander AF; Sauerwein RW; Jore MM; Theisen M
Front Immunol; 2019; 10():1256. PubMed ID: 31231386
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of anti-MSP3 and Pfs230 antibody responses and multiplicity of infection in asymptomatic children from southern Ghana.
Amoah LE; Acquah FK; Ayanful-Torgby R; Oppong A; Abankwa J; Obboh EK; Singh SK; Theisen M
Parasit Vectors; 2018 Jan; 11(1):13. PubMed ID: 29304870
[TBL] [Abstract][Full Text] [Related]
7. Immune Responses to Gametocyte Antigens in a Malaria Endemic Population-The African
Muthui MK; Kamau A; Bousema T; Blagborough AM; Bejon P; Kapulu MC
Front Immunol; 2019; 10():2480. PubMed ID: 31695697
[No Abstract] [Full Text] [Related]
8. Rapid onset of transmission-reducing antibodies in javanese migrants exposed to malaria in papua, indonesia.
Bousema JT; Roeffen W; van der Kolk M; de Vlas SJ; van de Vegte-Bolmer M; Bangs MJ; Teelen K; Kurniawan L; Maguire JD; Baird JK; Sauerwein RW
Am J Trop Med Hyg; 2006 Mar; 74(3):425-31. PubMed ID: 16525101
[TBL] [Abstract][Full Text] [Related]
9. Antibody responses to two new Lactococcus lactis-produced recombinant Pfs48/45 and Pfs230 proteins increase with age in malaria patients living in the Central Region of Ghana.
Acquah FK; Obboh EK; Asare K; Boampong JN; Nuvor SV; Singh SK; Theisen M; Williamson KC; Amoah LE
Malar J; 2017 Aug; 16(1):306. PubMed ID: 28764709
[TBL] [Abstract][Full Text] [Related]
10. Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins.
Singh K; Burkhardt M; Nakuchima S; Herrera R; Muratova O; Gittis AG; Kelnhofer E; Reiter K; Smelkinson M; Veltri D; Swihart BJ; Shimp R; Nguyen V; Zhang B; MacDonald NJ; Duffy PE; Garboczi DN; Narum DL
Commun Biol; 2020 Jul; 3(1):395. PubMed ID: 32709983
[TBL] [Abstract][Full Text] [Related]
11. Profiling the Quality and Quantity of Naturally Induced Antibody Responses Against Pfs230 and Pfs48/45 Among Non-Febrile Children Living in Southern Ghana: A Longitudinal Study.
Broni FK; Acquah FK; Obiri-Yeboah D; Obboh EK; Sarpong E; Amoah LE
Front Cell Infect Microbiol; 2021; 11():770821. PubMed ID: 34900755
[TBL] [Abstract][Full Text] [Related]
12. Naturally acquired antibody response to a Plasmodium falciparum chimeric vaccine candidate GMZ2.6c and its components (MSP-3, GLURP, and Pfs48/45) in individuals living in Brazilian malaria-endemic areas.
Baptista BO; de Souza ABL; Riccio EKP; Bianco-Junior C; Totino PRR; Martins da Silva JH; Theisen M; Singh SK; Amoah LE; Ribeiro-Alves M; Souza RM; Lima-Junior JC; Daniel-Ribeiro CT; Pratt-Riccio LR
Malar J; 2022 Jan; 21(1):6. PubMed ID: 34983540
[TBL] [Abstract][Full Text] [Related]
13. Modeling the impact of Plasmodium falciparum sexual stage immunity on the composition and dynamics of the human infectious reservoir for malaria in natural settings.
Ouédraogo AL; Eckhoff PA; Luty AJF; Roeffen W; Sauerwein RW; Bousema T; Wenger EA
PLoS Pathog; 2018 May; 14(5):e1007034. PubMed ID: 29742161
[TBL] [Abstract][Full Text] [Related]
14. Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite.
Mistarz UH; Singh SK; Nguyen TTTN; Roeffen W; Yang F; Lissau C; Madsen SM; Vrang A; Tiendrebeogo RW; Kana IH; Sauerwein RW; Theisen M; Rand KD
Pharm Res; 2017 Sep; 34(9):1970-1983. PubMed ID: 28646324
[TBL] [Abstract][Full Text] [Related]
15. Comparative functional potency of DNA vaccines encoding Plasmodium falciparum transmission blocking target antigens Pfs48/45 and Pfs25 administered alone or in combination by in vivo electroporation in rhesus macaques.
Datta D; Bansal GP; Grasperge B; Martin DS; Philipp M; Gerloff D; Ellefsen B; Hannaman D; Kumar N
Vaccine; 2017 Dec; 35(50):7049-7056. PubMed ID: 29132995
[TBL] [Abstract][Full Text] [Related]
16. Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine.
Theisen M; Jore MM; Sauerwein R
Expert Rev Vaccines; 2017 Apr; 16(4):329-336. PubMed ID: 28043178
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and malaria transmission reducing potency of Pfs48/45 and Pfs25 encoded by DNA vaccines administered by intramuscular electroporation.
Datta D; Bansal GP; Gerloff DL; Ellefsen B; Hannaman D; Kumar N
Vaccine; 2017 Jan; 35(2):264-272. PubMed ID: 27912985
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of Plasmodium falciparum transmission reducing immunity among primary school children in a malaria moderate transmission region in Zimbabwe.
Paul NH; Vengesai A; Mduluza T; Chipeta J; Midzi N; Bansal GP; Kumar N
Acta Trop; 2016 Nov; 163():103-8. PubMed ID: 27491342
[TBL] [Abstract][Full Text] [Related]
19. Improving the malaria transmission-blocking activity of a Plasmodium falciparum 48/45 based vaccine antigen by SpyTag/SpyCatcher mediated virus-like display.
Singh SK; Thrane S; Janitzek CM; Nielsen MA; Theander TG; Theisen M; Salanti A; Sander AF
Vaccine; 2017 Jun; 35(30):3726-3732. PubMed ID: 28578824
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
Rouhani M; Zakeri S; Mehrizi AA; Djadid ND
Malar J; 2015 Feb; 14():58. PubMed ID: 25652589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
